Icagen, Inc. Announces Management Changes

RESEARCH TRIANGLE PARK, N.C., Dec. 20, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that Seth V. Hetherington, M.D., SVP, Clinical and Regulatory Affairs, will be leaving the Company at the end of the year. Following his departure, Greg C. Rigdon, Ph.D., Vice President, New Product Development, will assume leadership responsibility for the Company's clinical development efforts.

Back to news